UNSPSC 85713909: Insertion of spacer into left metacarpophalangeal joint, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to insertion of spacer into left metacarpophalangeal joint, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0RHV38Z

UNSPSC 85713909 Insertion of spacer into left metacarpophalangeal joint, percutaneous approach is a Commodity code that shows little relevant recent activity. The code's nominal scope—a specific orthopedic surgical procedure—does not align with the recent state and local contract opportunities posted under this code number. The opportunities instead span disability medical evaluation services, surgical benefit carve-out programs, occupational medical surveillance, youth detention healthcare, pharmacy benefit management, and temporary health professional staffing. None of these solicitations involve metacarpophalangeal joint procedures or related implant procurement. The apparent mismatch suggests either a data-tagging error in the source records or that this code is used opportunistically by procurement systems without regard to its actual clinical definition.

State and local buyers posting under this code in recent months include the City of Phoenix Retirement Office (serving pension boards), the City of Long Beach, the Washington State Department of Transportation (via the Washington State Ferries), Harris County Juvenile Probation Department, Collier County Board of County Commissioners, and the County of Santa Clara Health System. Geographic activity spans Arizona, California, Washington, Florida, and Texas. Recent representative opportunities include the City of Phoenix's RFP for independent medical evaluation services (RTMRFP26001, due October 16, 2026) and the Washington State Department of Transportation's RFP for occupational medical surveillance services (RFP20260825, due October 9, 2026 with pre-bid August 31, 2026). Without evidence that the code is being used correctly for its stated clinical purpose, pursuit under this code is not advisable; business development professionals should verify the intended scope directly with issuing agencies if considering responses.